Calretinin gene promoter activity is differently regulated in neurons and cancer cells. Role of AP2-like cis element and zinc ions

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1678, Issue 1, 2004, Pages 14-21

  Billing Marczak, Katarzyna ^a   Ziemińska, Elzbieta ^b   Leśniak, Wiesława ^a   Łazarewicz, Jerzy W ^b   Kuźnicki, Jacek ^a,c  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

Author keywords

Activator protein 2; Adenocarcinoma; AP2; AP2 like element; Calretinin; Calretinin gene promoter; Cerebellar granule neuron; CR; Dithiothreitol; DTT; EF hand calcium binding protein; Electrophoretic mobility shift assay; EMSA; FCS; Fetal calf serum; Mesothelioma

Indexed keywords

CALRETININ; CIS ACTING ELEMENT; NUCLEAR PROTEIN;

ADENOCARCINOMA; ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CANCER CELL; CEREBELLUM; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GRANULE CELL; HUMAN; HUMAN CELL; MESOTHELIOMA; MULTIPOTENT STEM CELL; NERVE CELL DIFFERENTIATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RAT; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ADENOCARCINOMA; ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELLS, CULTURED; CEREBELLUM; COLONIC NEOPLASMS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MESOTHELIOMA; NEURONS; PROMOTER REGIONS (GENETICS); RATS; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; ZINC;

EID: 1842505629     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbaexp.2004.01.004     Document Type: Article

References (40)

1. Billing-Marczak K., Buzanska L., Winsky L., Nowotny M., Rudka T., Isaacs K., Belin M.F., Kuznicki J. AP2-like cis element is required for calretinin gene promoter activity in cells of neuronal phenotype differentiated from multipotent human cell line DEV. Biochim. Biophys. Acta. 1577:2002;412-420.
2. Celio M.R. Guidebook to the Calcium-Binding Proteins. 1996;Sambrook & Tooze Publication at Oxford Univ. Press, Oxford.
3. Dechesne C.J., Winsky L., Kim H.N., Goping G., Vu T.D., Wenthold R.J., Jacobowitz D.M. Identification and ultrastructural localization of a calretinin-like calcium-binding protein (protein 10) in the guinea pig and rat inner ear. Brain Res. 560:1991;139-148.
4. Hubbard M.J., McHugh N.J. Calbindin28kDa and calbindin30kDa (calretinin) are substantially localised in the particulate fraction of rat brain. FEBS Lett. 374:1995;333-337.
5. Winsky L., Kuznicki J. Distribution of calretinin, calbindin D28k, and parvalbumin in subcellular fractions of rat cerebellum: effects of calcium. J. Neurochem. 65:1995;381-388.
6. Hack N.J., Wride M.C., Charters K.M., Kater S.B., Parks T.N. Developmental changes in the subcellular localization of calretinin. J. Neurosci. 20:2000;RC67.
7. Schwaller B., Hermann B. Regulated redistribution of calretinins in WiDr cells. Cell Death Differ. 4:1997;325-333.
8. Billing-Marczak K., Kuznicki J. Calretinin-sensor or buffer-function still unclear. Pol. J. Pharmacol. 51:1999;173-178.
9. Hof P.R., Nimchinsky E.A., Celio M.R., Bouras C., Morrison J.H. Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease. Neurosci. Lett. 152:1993;145-148.
10. Lukas W., Jones K.A. Cortical neurons containing calretinin are selectively resistant to calcium overload and excitotoxicity in vitro. Neuroscience. 61:1994;307-316.
11. Vogt Weisenhorn D.M., Weruaga-Prieto E., Celio M.R. Calretinin- immunoreactivity in organotypic cultures of the rat cerebral cortex: effects of serum deprivation. Exp. Brain Res. 108:1996;101-112.
12. D'Orlando C., Fellay B., Schwaller B., Salicio V., Bloc A., Gotzos V., Celio M.R. Calretinin and calbindin D-28k delay the onset of cell death after excitotoxic stimulation in transfected P19 cells. Brain Res. 909:2001;145-158.
13. D'Orlando C., Celio M.R., Schwaller B. Calretinin and calbindin D-28k, but not parvalbumin protect against glutamate-induced delayed excitotoxicity in transfected N18-RE 105 neuroblastoma-retina hybrid cells. Brain Res. 945:2002;181-190.
14. Mockel V., Fischer G. Vulnerability to excitotoxic stimuli of cultured rat hippocampal neurons containing the calcium-binding proteins calretinin and calbindin D28K. Brain Res. 648:1994;109-120.
15. Kuznicki J., Isaacs K.R., Jacobowitz D.M. The expression of calretinin in transfected PC12 cells provides no protection against Ca(2+)-overload or trophic factor deprivation. Biochim. Biophys. Acta. 1313:1996;194-200.
16. Schurmans S., Schiffmann S.N., Gurden H., Lemaire M., Lipp H.P., Schwam V., Pochet R., Imperato A., Bohme G.A., Parmentier M. Impaired long-term potentiation induction in dentate gyrus of calretinin-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 94:1997;10415-10420.
17. Billing-Marczak K., Przybyszewska M., Kuznicki J. Measurements of [Ca2+] using fura-2 in glioma C6 cells expressing calretinin with GFP as a marker of transfection: no Ca2+-buffering provided by calretinin. Biochim. Biophys. Acta. 1449:1999;169-177.
18. Isaacs K.R., Wolpoe M.E., Jacobowitz D.M. Vulnerability to calcium-induced neurotoxicity in cultured neurons expressing calretinin. Exp. Neurol. 163:2000;311-323.
19. Edmonds B., Reyes R., Schwaller B., Roberts W.M. Calretinin modifies presynaptic calcium signaling in frog saccular hair cells. Nat. Neurosci. 3:2000;786-790.
20. Rogers J.H. Calretinin: a gene for a novel calcium-binding protein expressed principally in neurons. [published erratum appears in J. Cell. Biol. 1990 May;110(5):1845] J. Cell Biol. 105:1987;1343-1353.
21. Winsky L., Nakata H., Martin B.M., Jacobowitz D.M. Isolation, partial amino acid sequence, and immunohistochemical localization of a brain-specific calcium-binding protein. Proc. Natl. Acad. Sci. U. S. A. 86:1989;10139-10143.
22. Resibois A., Rogers J.H. Calretinin in rat brain: an immunohistochemical study. Neuroscience. 46:1992;101-134.
23. Marini A.M., Strauss K.I., Jacobowitz D.M. Calretinin-containing neurons in rat cerebellar granule cell cultures. Brain Res. Bull. 42:1997;279-288.
24. Pohl V., Van Rampelbergh J., Mellaert S., Parmentier M., Pochet R. Calretinin in rat ovary: an in situ hybridization and immunohistochemical study. Biochim. Biophys. Acta. 1160:1992;87-94.
25. Strauss K.I., Isaacs K.R., Ha Q.N., Jacobowitz D.M. Calretinin is expressed in the Leydig cells of rat testis. Biochim. Biophys. Acta. 1219:1994;435-440.
26. Augusto D., Leteurtre E., De La Taille A., Gosselin B., Leroy X. Calretinin: a valuable marker of normal and neoplastic Leydig cells of the testis. Appl. Immunohistochem. Mol. Morphol. 10:2002;159-162.
27. Gotzos V., Schwaller B., Hetzel N., Bustos-Castillo M., Celio M.R. Expression of the calcium binding protein calretinin in WiDr cells and its correlation to their cell cycle. Exp. Cell Res. 202:1992;292-302.
28. Gotzos V., Schwaller B., Gander J.C., Bustos-Castillo M., Celio M.R. Heterogeneity of expression of the calcium-binding protein calretinin in human colonic cancer cell lines. Anticancer Res. 16:1996;3491-3498.
29. Gotzos V., Vogt P., Celio M.R. The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type. Pathol. Res. Pract. 192:1996;137-147.
30. Doglioni C., Tos A.P., Laurino L., Iuzzolino P., Chiarelli C., Celio M.R., Viale G. Calretinin: a novel immunocytochemical marker for mesothelioma. Am. J. Surg. Pathol. 20:1996;1037-1046.
31. Barberis M.C., Faleri M., Veronese S., Casadio C., Viale G. Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions. Acta Cytol. 41:1997;1757-1761.
32. Saydan N., Salicio V., Cappelli-Gotzos B., Gotzos V. Expression of calretinin in human mesothelioma cell lines and cell cycle analysis by flow cytometry. Anticancer Res. 21:2001;181-188.
33. Terracciano L.M., Mhawech P., Suess K., D'Armiento M., Lehmann F.S., Jundt G., Moch H., Sauter G., Mihatsch M.J. Calretinin as a marker for cardiac myxoma. Diagnostic and histogenetic considerations. Am. J. Clin. Pathol. 114:2000;754-759.
34. Palczewska M., Groves P., Kaleta A., Batta G., Kuznicki J. NMR and biochemical characterization of calretinin reveals differences to calbindin D28k. XII International Symposium on Calcium Binding Proteins and Calcium Function in Health and Disease. 2002;128. Cavalese, Italy.
35. Stuart G.W., Searle P.F., Palmiter R.D. Identification of multiple metal regulatory elements in mouse metallothionein-I promoter by assaying synthetic sequences. Nature. 317:1985;828-831.
36. Schousboe A., Drejer J., Hansen G.H., Meier E. Cultured neurons as model systems for biochemical and pharmacological studies on receptors for neurotransmitter amino acids. Dev. Neurosci. 7:1985;252-262.
37. Ausubel F.M. Introduction of DNA into mammalian cells. Ausubel F.M.E.A. Short Protocols in Molecular Biology. 3rd ed. 1995;5-9 Wiley, New York.
38. Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:1995;4878-4884.
39. Ishii K., Usui S., Yamamoto H., Sugimura Y., Tatematsu M., Hirano K. Decreases of metallothionein and aminopeptidase N in renal cancer tissues. J. Biochem. (Tokyo). 129:2001;253-258.
40. Hershfinkel M., Moran A., Grossman N., Sekler I. A zinc-sensing receptor triggers the release of intracellular Ca2+ and regulates ion transport. Proc. Natl. Acad. Sci. U. S. A. 98:2001;11749-11754.